Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Steffanie Halberstadt
A High Response Rate to Liposomal Doxorubicin Is Seen Among Women With BRCA Mutations Treated for Recurrent Epithelial Ovarian Cancer
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
Non‑pegylated Liposomal Doxorubicin for Patients With Recurrent Ovarian Cancer: A Multicentric Phase II Trial
Oncology Letters
Cancer Research
Oncology
BRCA Mutations in Women With Inflammatory Breast Cancer
Cancer
Cancer Research
Oncology
A Case of Metaplastic Breast Cancer With Prolonged Response to Single Agent Liposomal Doxorubicin
Cureus
Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin
Clinical Medicine Reviews in Women's Health
Preterm Delivery Is Associated With an Increased Risk of Epithelial Ovarian Cancer Among Parous Women
International Journal of Cancer
Cancer Research
Oncology
Phase 1 Trial of Olaparib and Oral Cyclophosphamide in BRCA Breast Cancer, Recurrent BRCA Ovarian Cancer, Non-Brca Triple-Negative Breast Cancer, and Non-Brca Ovarian Cancer
British Journal of Cancer
Cancer Research
Oncology
A Systematic Review and Economic Evaluation of Pegylated Liposomal Doxorubicin Hydrochloride for Ovarian Cancer
Health Technology Assessment
Medicine
Health Policy
BRCA Mutations in the Manifestation and Treatment of Ovarian Cancer
Oncotarget
Oncology
Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
JAMA - Journal of the American Medical Association
Medicine
